NCT01444586 Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE) Status COMPLETED Phase N/A
NCT01442792 Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention Status COMPLETED Phase PHASE2
NCT01439152 Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors. Status COMPLETED Phase PHASE1
NCT01436825 Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients Status COMPLETED Phase N/A
NCT01436526 Bioequivalence Study in Healthy Subjects, 2*5 mg Tablets Rivaroxaban Versus 1*10 mg Tablet Rivaroxaban Status COMPLETED Phase PHASE1
NCT01432704 Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) Status COMPLETED Phase PHASE2/PHASE3
NCT01430533 Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation Status COMPLETED Phase PHASE1
NCT01419327 Fosrenol Post-marketing Surveillance for Hemodialysis in Japan Status COMPLETED Phase N/A
NCT01413958 Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1) Status COMPLETED Phase PHASE3
NCT01412671 Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program Status COMPLETED Phase N/A